News
Health Matters: Health Canada approves Ozempic to help reduce kidney decline
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 diabetes. The decision comes after an international clinical trial found the risk of deteriorating kidney function was 24 per cent lower in patients taking Ozempic compared to those taking a placebo injection.
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.
GLP-1 receptor agonist medications like Ozempic have been talked about so much that its side effects (like nausea and ...
Green Matters on MSN2d
Ozempic Sparks Both Weight Loss Success Stories and Major Lawsuits in 2025
The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...
Fitness experts say using weight-loss drugs is just one piece of the puzzle for many attempting to live healthier ...
If the shoe fits. Ozempic and other weight loss drugs could have a gnarly side effect dubbed “Ozempic-feet,” according to a report. The popular pound-shedding prescription drug is known… ...
Earlier this month, it said it expects continued competition from copycat versions of its blockbuster obesity drug Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback